Form4insider filings, from the source

SEC Form 4 · accession 0001104659-19-010365

MARRONE BIO INNOVATIONS INC · MBII

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Feb 14, 2019
Accepted (ET)
Feb 25, 2019 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Feb 14, 2019P200$1.50A7,128,770D
Common StockF1,F2,F3Feb 21, 2019S1,500,000$1.57D5,628,770D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

* Pursuant to a Power of Attorney, dated as of February 27, 2018, by and among the Reporting Persons. Exhibit 24.1 Power of Attorney, dated as of February 27, 2018, by and among the Reporting Persons, incorporated herein by reference to Exhibit 3 to Schedule 13D/A filed by the Reporting Persons on March 13, 2018 with respect to Ablynx NV (File No. 005-90201).